Lack of effect of sacral nerve stimulation for incontinence in patients with systemic sclerosis

Colorectal Disease

Volumn 17, Issue 10, 2015, Pages 903-907

  Butt, S K ^a   Alam, A ^a   Cohen, R ^a   Krogh, K ^b   Buntzen, S ^b   Emmanuel, A ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Faecal; Incontinence; Sacral; Scleroderma; Stimulation; Wexner

Indexed keywords

ADULT; AGED; ANORECTAL PRESSURE; ARTICLE; CASE STUDY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATORY DESIRE VOLUME; DIGESTIVE TRACT PARAMETERS; FECES INCONTINENCE; FEMALE; HUMAN; MAXIMUM TOLERATED VOLUME; MIDDLE AGED; MULTICENTER STUDY; MUSCLE ATROPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SACRAL NERVE STIMULATION; SPHINCTER; SYSTEMIC SCLEROSIS; TREATMENT FAILURE; URGE VOLUME; WEXNER SCORE; CLINICAL TRIAL; COHORT ANALYSIS; COMPLICATION; DENMARK; ELECTROTHERAPY; FECAL INCONTINENCE; GREAT BRITAIN; LUMBOSACRAL PLEXUS; PATHOPHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; UNIVERSITY HOSPITAL;

ADULT; AGED; COHORT STUDIES; DENMARK; ELECTRIC STIMULATION THERAPY; FECAL INCONTINENCE; FEMALE; GREAT BRITAIN; HOSPITALS, UNIVERSITY; HUMANS; LUMBOSACRAL PLEXUS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE;

EID: 84941203289     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12969     Document Type: Article

References (19)

1. Sallam H, McNearney TA, Chen JDZ. Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther 2006; 23: 691-712.
2. Thoua NM, Schizas A, Forbes A, Denton CP, Emmanuel AV. Internal anal sphincter atrophy in patients with systemic sclerosis. Rheumatology (Oxford) 2011; 50: 1596-602.
3. Trezza M, Krogh K, Egekvist H, Bjerring P, Laurberg S. Bowel problems in patients with systemic sclerosis. Scand J Gastroenterol 1999; 34: 409-13.
4. Fynne L, Worsøe J, Laurberg S, Krogh K. Faecal incontinence in patients with systemic sclerosis: is an impaired internal anal sphincter the only cause? Scand J Rheumatol 2011; 40: 462-6.
5. Fynne L, Luft F, Gregersen H et al. Distensibility of the anal canal in patients with systemic sclerosis: a study with the functional lumen imaging probe. Colorectal Dis 2013; 15: e40-7.
6. Bajwa A, Emmanuel A. The physiology of continence and evacuation. Best Pract Res Clin Gastroenterol 2009; 23: 477-85.
7. Thoua NM, Abdel-Halim M, Forbes A, Denton CP, Emmanuel A V.Fecal incontinence in systemic sclerosis is secondary to neuropathy. Am J Gastroenterol 2012; 107: 597-603.
8. NIfHaCE (NICE). Faecal incontinence. The management of faecal incontinence in adults Report No 49. UK: NIfHaCE (NICE), 2009.
9. Jarrett MED, Mowatt G, Glazener CMA et al. Systematic review of sacral nerve stimulation for faecal incontinence and constipation. Br J Surg 2004; 91: 1559-69.
10. Wexner SD, Coller JA, Devroede G et al. Sacral nerve stimulation for fecal incontinence: results of a 120-patient prospective multicenter study. Ann Surg 2010; 251: 441-9.
11. Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum 1993; 36: 77-97.
12. Evans RC, Kamm MA, Hinton JM, Lennard-Jones JE. The normal range and a simple diagram for recording whole gut transit time. Int J Colorectal Dis 1992; 7: 15-7.
13. Matzel KE, Stadelmaier U, Hohenfellner M, Gall FP. [Permanent electrostimulation of sacral spinal nerves with an implantable neurostimulator in treatment of fecal incontinence]. Chirurg 1995; 66: 813-7.
14. Whitehead WE, Rao SSC, Lowry A et al. Treatment of fecal incontinence: state of the science summary for the national institute of diabetes and digestive and kidney diseases workshop. Am J Gastroenterol 2015; 110: 138-146.
15. Kenefick NJ, Vaizey CJ, Nicholls RJ, Cohen R, Kamm MA. Sacral nerve stimulation for faecal incontinence due to systemic sclerosis. Gut 2002; 51: 881-3.
16. Dudding TC, Parés D, Vaizey CJ, Kamm MA. Sacral nerve stimulation for the treatment of faecal incontinence related to dysfunction of the internal anal sphincter. Int J Colorectal Dis 2010; 25: 625-30.
17. Heyt GJ, Oh MK, Alemzadeh N et al. Impaired rectoanal inhibitory response in scleroderma (systemic sclerosis): an association with fecal incontinence. Dig Dis Sci 2004; 49: 1040-5.
18. Lock G, Straub RH, Zeuner M et al. Association of autonomic nervous dysfunction and esophageal dysmotility in systemic sclerosis. J Rheumatol 1998; 25: 1330-5.
19. Gourcerol G, Vitton V, Leroi AM, Michot F, Abysique A, Bouvier M. How sacral nerve stimulation works in patients with faecal incontinence. Colorectal Dis 2011; 13: e203-11.